drugset / Trial / NCT00479648
A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants
RandomizedParallel-groupQuadruple-blind
Summary
Current influenza vaccines have a reduced efficacy in the elderly. This study will investigate the immunogenicity, safety and tolerability of an adjuvanted influenza vaccine in elderly participants.
Timeline
- Start
- 2007-05
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSL412 | Vaccine | — | — |
| Comparator | Inactivated Trivalent Influenza Vaccine | Vaccine | — | — |